Recent News (DJ)
Armistice Capital Versus RTW and Perceptive: Biotech Positioning Amid Sector Volatility
Armistice Capital’s fourth-quarter 2024 portfolio adjustments reveal calculated moves within the biopharmaceutical sector, contrasting with broader hedge fund approaches during a period of ...

